HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan C Wang Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2020Genomic stability at the coding regions of the multidrug transporter gene ABCB1: insights into the development of alternative drug resistance mechanisms in human leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan C Wang Research Topics

Disease

6Ovarian Neoplasms (Ovarian Cancer)
12/2018 - 11/2003
4Neoplasms (Cancer)
12/2018 - 11/2003
3Carcinoma (Carcinomatosis)
05/2017 - 11/2003
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2020
1Leukemia
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2015
1Genomic Instability
01/2006
1Sarcoma (Soft Tissue Sarcoma)
10/2005

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2020 - 10/2005
4Paclitaxel (Taxol)FDA LinkGeneric
05/2017 - 01/2006
2valspodar (PSC 833)IBA
05/2017 - 01/2015
2taxaneIBA
05/2017 - 01/2006
2Docetaxel (Taxotere)FDA Link
05/2017 - 01/2006
2Taxoids (Taxanes)IBA
05/2017 - 01/2006
2Carboplatin (JM8)FDA LinkGeneric
10/2015 - 10/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2006 - 11/2003
1Etoposide (VP 16)FDA LinkGeneric
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Drug CombinationsIBA
01/2020
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020
1TubulinIBA
05/2017
1Biomarkers (Surrogate Marker)IBA
05/2017
1cabazitaxelFDA Link
01/2015
1ChemokinesIBA
10/2014
1X-Box Binding Protein 1IBA
11/2003
1Ephrin-B1 (Ephrin B1)IBA
11/2003
1MesothelinIBA
11/2003
1Estrogen ReceptorsIBA
11/2003

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2018
1Time-to-Treatment
12/2018
1Therapeutics
10/2014